⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 15, 2025

Supplementary Figure S5 from Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-grade Serous Tumors with Histologic Transformation

M. Herman Chui Eun-Young Kang Ryan Kahn Sarah Chiang Qin Zhou Alexia Iasonos Beryl Manning‐Geist Pier Selenica Arnaud Da Cruz Paula Kara Long Roche Britta Weigelt Rachel N. Grisham

View Full Paper

Ask AI

Bookmark

Share

Key Points

Main finding indicates significant differences in overall survival among subgroups of ovarian low-grade serous tumors.
Key evidence from subgroup analyses reveals distinct molecular landscape variations influencing patient prognosis.
Approach utilized clinicopathologic data to assess survival outcomes in patients with low-grade serous tumors.
Significance lies in providing insights that may refine prognostic assessment and treatment strategies for these tumors.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Overall survival analysis highlights subgroup differences in ovarian low-grade serous tumors, suggesting new prognostic implications.

Abstract

Overall survival subgroup analyses

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chui et al. (2025) studied this question.

synapsesocial.com/papers/689a02bce6551bb0af8cc62c https://doi.org/10.1158/1078-0432.29568310

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S4 from Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-grade Serous Tumors with Histologic Transformation2025
2Supplementary Figure S1 from Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-grade Serous Tumors with Histologic Transformation2025
3Supplementary Figure S2 from Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-grade Serous Tumors with Histologic Transformation2025
4Supplementary Figure S3 from Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-grade Serous Tumors with Histologic Transformation2025
5Data from Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-grade Serous Tumors with Histologic Transformation2025